» Articles » PMID: 8144142

Immunocytochemical Localization of Oestrogen and Progesterone Receptors in Primary Adenocarcinoma of the Cervix

Overview
Journal Histopathology
Date 1994 Jan 1
PMID 8144142
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Archival material from 47 primary invasive adenocarcinomas of the uterine cervix was examined using an immunocytochemical technique for detection of oestrogen receptor and progesterone receptor in paraffin-wax embedded tissues. Immunostaining for oestrogen receptor was noted within tumour cells in 12 cervical adenocarcinomas while 13 tumours contained progesterone receptor. Eleven cervical adenocarcinomas expressed both oestrogen and progesterone receptor simultaneously. There was no association between steroid receptor status and major histological subtype, grade of tumour, clinical stage or age of patient at presentation. However, oestrogen receptor immunoreactivity was associated with disease-free survival. This preliminary study raises the possibility that, as in breast carcinoma, steroid receptor status may be a useful prognostic factor in adenocarcinoma of the cervix.

Citing Articles

Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma.

Ino Y, Akimoto T, Takasawa A, Takasawa K, Aoyama T, Ueda A Histol Histopathol. 2019; 35(4):351-359.

PMID: 31483053 DOI: 10.14670/HH-18-157.


The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review.

Kubecek O, Laco J, Spacek J, Petera J, Kopecky J, Kubeckova A Clin Exp Metastasis. 2017; 34(5):295-307.

PMID: 28730323 PMC: 5561159. DOI: 10.1007/s10585-017-9856-8.


Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.

Miura K, Ishida K, Fujibuchi W, Ito A, Niikura H, Ogawa H Surg Today. 2012; 42(6):515-25.

PMID: 22441574 DOI: 10.1007/s00595-012-0167-z.


Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.

Alkushi A, Irving J, Hsu F, Dupuis B, Liu C, Rijn M Virchows Arch. 2003; 442(3):271-7.

PMID: 12647218 DOI: 10.1007/s00428-002-0752-4.